Balentine LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.

Quarter-by-quarter ownership
Balentine LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q2 2020$2,000
-33.3%
395
-28.7%
0.00%
Q4 2018$3,000
-40.0%
5540.0%0.00%
Q3 2018$5,000
-58.3%
554
-70.9%
0.00%
-100.0%
Q4 2017$12,000
-20.0%
1,9020.0%0.00%0.0%
Q3 2017$15,000
-50.0%
1,902
-55.2%
0.00%
-66.7%
Q2 2017$30,000
+87.5%
4,2410.0%0.00%
+50.0%
Q1 2017$16,000
+77.8%
4,2410.0%0.00%
+100.0%
Q4 2016$9,000
-18.2%
4,2410.0%0.00%
-50.0%
Q3 2016$11,0004,2410.00%
Other shareholders
IMMUNOGEN INC shareholders Q3 2020
NameSharesValueWeighting ↓
QVT Financial LP 1,375,900$6,329,0001.08%
Redmile Group, LLC 12,006,979$55,232,0001.02%
Birchview Capital, LP 190,000$874,0000.53%
Fernwood Investment Management, LLC 179,340$825,0000.41%
HealthCor Management, L.P. 1,200,000$5,520,0000.23%
Grace Capital 49,500$228,0000.20%
TWIN FOCUS CAPITAL PARTNERS, LLC 104,068$479,0000.19%
Virtus ETF Advisers LLC 79,795$367,0000.17%
PINNACLE ASSOCIATES LTD 1,087,034$5,000,0000.12%
HUSSMAN STRATEGIC ADVISORS, INC. 100,000$460,0000.12%
View complete list of IMMUNOGEN INC shareholders